GenMont Biotech Incorporation (TPE:3164)

TPE:3164 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	102.7	103.73	110.51	55.6	133.69	169.95
Short-Term Investments	251.94	261.62	248.13	272.71	267.26	251.78
Cash & Short-Term Investments	354.64	365.36	358.64	328.3	400.94	421.73
Cash Growth	20.27%	1.87%	9.24%	-18.12%	-4.93%	-9.33%
Accounts Receivable	50.81	46.16	31.6	38.23	50.36	54.01
Other Receivables	1.58	0.74	1.73	1.79	1.4	1.05
Receivables	52.38	46.89	33.33	40.02	51.76	55.06
Inventory	68.41	70.39	77.67	88.12	55.3	37.06
Prepaid Expenses	5.8	5.23	4.92	9.07	13.49	66.94
Other Current Assets	70.35	67.44	67.17	-	-	-
Total Current Assets	551.58	555.31	541.73	465.51	521.5	580.79
Property, Plant & Equipment	983.88	976.29	1,037	1,060	1,113	1,045
Long-Term Investments	-	-	6.09	7.32	26.52	34.68
Other Intangible Assets	1.86	2.01	2.16	2.26	0.24	0.33
Long-Term Deferred Tax Assets	51.84	51.84	42.04	39.7	22.73	12.31
Other Long-Term Assets	81.98	79.64	79.89	78.29	11.59	24.8
Total Assets	1,671	1,665	1,709	1,653	1,696	1,698

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	11.02	8.14	6.3	7.85	14.37	11.39
Short-Term Debt	44.46	23.5	20.48	-	-	-
Current Portion of Long-Term Debt	8.48	7.31	12.24	2.24	-	-
Current Portion of Leases	0.83	1.76	2.4	2.36	1.06	2.11
Current Income Taxes Payable	30.78	22.74	12.19	18.95	28.44	33.82
Current Unearned Revenue	20.77	22.04	40.05	33.98	25.76	25.33
Other Current Liabilities	37.24	44.29	46.48	81.01	91.16	66.51
Total Current Liabilities	153.58	129.78	140.15	146.39	160.78	139.17
Long-Term Debt	43.33	44.9	49.23	20.11	-	-
Long-Term Leases	37.24	32.84	34.26	33.6	33.49	30.62
Long-Term Deferred Tax Liabilities	5.52	5.52	3.11	1.59	1.96	1.54
Other Long-Term Liabilities	2.32	2.32	2.32	2.37	2.37	2.32
Total Liabilities	241.98	215.35	229.07	204.06	198.59	173.65

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	860.1	860.1	865.11	865.11	863.71	863.71
Additional Paid-In Capital	334.57	351.77	353.74	377.1	375.69	375.69
Retained Earnings	81.42	113.34	128.02	89.97	117.5	154.87
Comprehensive Income & Other	34.2	5.66	4.9	-15.88	-5.58	-17.83
Total Common Equity	1,310	1,331	1,352	1,316	1,351	1,376
Minority Interest	118.86	118.85	127.9	132.82	145.89	147.95
Shareholders' Equity	1,429	1,450	1,480	1,449	1,497	1,524
Total Liabilities & Equity	1,671	1,665	1,709	1,653	1,696	1,698

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	134.34	110.31	118.61	58.31	34.55	32.73
Net Cash (Debt)	220.3	255.05	240.03	270	366.4	389
Net Cash Growth	17.39%	6.26%	-11.10%	-26.31%	-5.81%	-9.70%
Net Cash Per Share	2.55	2.95	2.77	3.12	4.23	4.48
Filing Date Shares Outstanding	86.35	86.01	86.51	86.51	86.37	86.37
Total Common Shares Outstanding	86.35	86.01	86.51	86.51	86.37	86.37
Working Capital	398	425.53	401.59	319.12	360.73	441.62
Book Value Per Share	15.17	15.47	15.63	15.22	15.65	15.94
Tangible Book Value	1,308	1,329	1,350	1,314	1,351	1,376
Tangible Book Value Per Share	15.15	15.45	15.60	15.19	15.64	15.93
Buildings	-	926.21	923.19	886.14	877.91	168.74
Machinery	-	492.34	489.48	481.71	419.15	234.11
Construction In Progress	-	-	0.02	0.03	75.24	858.62

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error